Jack Cuzick on the International Breast Cancer Intervention Study II – The ASCO Post

Jack Cuzick, PhD, of Queen Mary University of London, discusses the substantially greater benefits of anastrozole as compared with tamoxifen in terms of preventing breast cancer, with no increase in fractures or other reported serious side effects (Abstract GS4-04). Nicholas C. Turner, MD, PhD, of The Royal Marsden NHS Foundation Trust, discusses findings…

Read the full article here

Related Articles